G+FLAS Life Sciences

History

YearDetail
2014 G+FLAS is a biotech startup company established in 2014 based on the 'genome editing' technology of Dr. Sunghwa Choe of Seoul National University.
2018 Naturegenic Inc., a U.S.-based company known for crop improvement based on CRISPR technology and founded by Dr. Choe, was acquired by the company to construct a domestic-overseas network dedicated to the research and development of CRISPR Anti-Cancer Agent.
2020 The company signed a memorandum of understanding with KangStem Biotech to develop cell therapy that utilizes genome editing technology.
AI Sentiment